Original articleClinical endoscopyStent-associated esophagorespiratory fistulas: incidence and risk factors
Section snippets
Methods
A retrospective cohort was established to identify the overall incidence and demographics of SERF. A case-control study was then performed to assess risk factors for development of SERF. The study was approved by the Mayo Clinic Institutional Review Board.
Results
A total of 443 patients who underwent esophageal stent placement were identified. A total of 46 were diagnosed as having ERF before stent placement and were excluded from this study. Of the remaining 397 patients, 16 were subsequently diagnosed with ERF. We also identified 5 patients who underwent esophageal stent placement at other institutions and who developed SERF and subsequently received care at our institution and 1 patient with SERF whose stent was placed before our predetermined time
Discussion
Symptom palliation is a major goal of treatment for many patients with esophageal cancer. Malignant dysphagia may be palliated with esophageal SESs,11 brachytherapy,12 chemoradiation therapy,13 photodynamic therapy,14 or surgery.15 Esophageal SESs are commonly used because of ease of insertion and demonstrated efficacy.1, 2, 3 SESs have become accepted in the treatment of benign esophageal conditions such as postoperative leaks, perforations, strictures, and fistulas.5, 6
Despite the benefits of
References (24)
- et al.
Stents for proximal esophageal cancer: a case-control study
Gastrointest Endosc
(2011) - et al.
Evolving role of self-expanding metal stents in the treatment of malignant dysphagia and fistulas
Gastrointest Endosc
(2007) Expandable stents for benign esophageal disease
Gastrointest Endosc Clin N Am
(2011)- et al.
Self-expanding plastic stents in treatment of benign esophageal conditions
Gastrointest Endosc
(2008) - et al.
Palliation of malignant dysphagis and fistulae with coated expandable metal stents: experience with 101 patients
Gastrointest Endosc
(1998) - et al.
Expandable stents for malignant esophageal disease
Gastrointest Endosc Clin N Am
(2011) - et al.
Predictors of outcome of single-dose brachytherapy for the palliation of dysphagia from esophageal cancer
Brachytherapy
(2006) Photodynamic therapy
Gastrointest Endosc Clin N Am
(2011)- et al.
Surgical palliation for Barrett's esophagus cancer
Surg Oncol Clin N Am
(2009) - et al.
Human tissue responses to metal stents implanted in vivo for palliation of malignant stenosis
Gastrointest Endosc
(1996)
Prior radiation and chemotherapy increase the risk of life-threatening complications after insertion of metallic stents for esophagogastric malignancy
Gastrointest Endosc
Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial
Lancet
Cited by (55)
Characteristics and Outcomes of Airway Involvement in Esophageal Cancer
2021, Annals of Thoracic SurgeryCitation Excerpt :We report an association between airway complications and previous surgery, radiotherapy, chemotherapy, and esophageal stenting. Previous studies have also reported a higher risk of TEF with esophageal stenting or radiotherapy.10-12 Development of TEF in these cases is multifactorial and is largely related to injury of the esophagus from radiation and expanding pressure of the stent.12
Outcomes of self-expandable metal stent placement for malignant oesophageal strictures
2020, Clinical RadiologyImpact of radiotherapy on adverse events of self-expanding metallic stents in patients with esophageal cancer
2023, Diseases of the EsophagusEsophageal stenting with minimally-invasive surgical intervention for delayed spontaneous esophageal perforation
2023, Journal of Thoracic Disease
DISCLOSURE: All authors disclosed no financial relationships relevant to this publication.
See CME section; p. 280.
If you would like to chat with an author of this article, you may contact Dr Topazian at [email protected].